Copeptin in Aortic Valve Replacement

NCT01648647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2012-07-24

No results posted yet for this study

Summary

Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures

Conditions

  • Copeptin in Patients Undergoing Aortic Valve Replacement

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01648647 on ClinicalTrials.gov